Showing results (21-30 of 255) with videos related to
Sort By:
Pageof 26
The American Journal of Medicine|September 15, 2020
Proton Pump Inhibitors Versus Histamine-2 Receptor Antagonists Likely Increase Mortality in Critical Care: An Updated Meta-AnalysisTodd C Lee, Marnie Goodwin Wilson, Alexander Lawandi, et al.BMC Infectious Diseases|June 13, 2018
Screening swabs surpass traditional risk factors as predictors of MRSA bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.Infection Control and Hospital Epidemiology|January 25, 2020
Using VRE screening tests to predict vancomycin resistance in enterococcal bacteremiaGuillaume Butler-Laporte, Matthew P Cheng, Emily G McDonald, et al.Journal of Hospital Medicine|February 25, 2015
Reduction of inappropriate exit prescriptions for proton pump inhibitors: A before-after study using education paired with a web-based quality-improvement toolEmily G McDonald, Janelle Jones, Laurence Green, et al.Journal of the American Geriatrics Society|March 2, 2018
EMPOWERing Hospitalized Older Adults to Deprescribe Sedative Hypnotics: A Pilot StudyMarnie Goodwin Wilson, Todd C Lee, Aaron Hass, et al.CMAJ Open|July 12, 2022
Patient empowerment brochures to increase gabapentinoid deprescribing: protocol for the prospective, controlled before-and-after GABA-WHY trialJerome Williams, Marc-Alexandre Gingras, Robert Dubé, et al.Journal of Hospital Medicine|May 22, 2019
Retrospective Cohort Study of the Prevalence of Off-label Gabapentinoid Prescriptions in Hospitalized Medical PatientsMarc-Alexandre Gingras, Anthony Lieu, Louise Papillon-Ferland, et al.Open Forum Infectious Diseases|February 15, 2022
Outpatient Therapies for COVID-19: How Do We Choose?Todd C Lee, Andrew M Morris, Steven A Grover, et al.The American Journal of Medicine|June 16, 2018
Diastolic Hypotension May Attenuate Benefits from Intensive Systolic Targets: Secondary Analysis of a Randomized Controlled TrialTodd C Lee, Rodrigo B Cavalcanti, Emily G McDonald, et al.Canadian Journal of Kidney Health and Disease|May 19, 2022
Deprescribing Opportunities for Hospitalized Patients With End-Stage Kidney Disease on Hemodialysis: A Secondary Analysis of the MedSafer Cluster Randomized Controlled TrialJoseph Moryousef, Émilie Bortolussi-Courval, Tiina Podymow, et al.Pageof 26